Navigation Links
New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder
Date:6/9/2008

First Extensive Report of Bile Acid Aberration in Type 2 Diabetes Patients

Warrants Further Study

EMERYVILLE, Calif. and PARSIPPANY, N.J., June 9 /PRNewswire-FirstCall/ -- KineMed, Inc., and Daiichi Sankyo, Inc., announced that researchers have discovered a key difference in bile acid metabolism in people with type 2 diabetes which may suggest a newly identified underlying disorder.

It has long been known that bile acids help the body absorb fat and cholesterol. In the last decade, we learned that bile acids are important signaling molecules that regulate the metabolism of glucose, fat, and energy. And until now, there has been only preliminary data suggesting alterations in bile acid metabolism in people with type 2 diabetes. Now new data highlight crucial alterations in bile acid metabolism in this population. Researchers reported results from the first controlled study addressing this issue, which they hope will lead to a better understanding of how bile acid metabolism is impacted in people with type 2 diabetes.

The study found that the most important bile acid, cholic acid (CA), had a significantly higher synthesis rate in people with type 2 diabetes than in patients with normal glucose levels. Researchers also learned that the rate at which deoxycholic acid (DCA) was recycled back into the liver (i.e. DCA input rate) was almost twice as great in those with type 2 diabetes as in the healthy subjects. In addition, the total amount of bile acid synthesized by the liver was elevated, although not statistically significantly, in people who have type 2 diabetes as compared to the healthy control group.

KineMed, Inc., a pathway-based drug discovery and development company, initiated the research which used their proprietary translational medicine technology, KineMarker(TM). The results from the study were presented at the American Diabetes Association's 68th Scientific Sessions. The research was funded with
'/>"/>

SOURCE KineMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Discovery Leads to Earlier Diagnosis of Type 1 Diabetes
2. New Gene Discovery Suggests Which Patients CTIs Brostallicin May Benefit
3. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007
4. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722
5. Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec
6. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
7. FASgen Announces a New Discovery in Obesity Research
8. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
9. Nobel Prize-Winning Discovery
10. FASgen Announces New Discovery for Treatment of Stroke
11. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...CHICAGO, Nov. 28 Siemens Healthca... its Tim ® (Total imaging matrix) technology...ut) engine. Both technologies are introduced in th... new MAGNETOM Skyra* 3T scanners at the 95th Scien...cal Society of North America (RSNA) from November ...
(Date:11/27/2009)..., Another option to prevent illnesses caused by ...RING, Md., Nov. 27 The ...griflu for people ages 18 years and older to preve...d B. ,, (Logo: http://www.newscom.com/cgi-bi...red by Novartis Vaccines and Diagnostics in Siena,...
(Date:11/27/2009)... SALT LAKE CITY, Nov. 27 ...s, Inc. (NYSE: VAR ), a premier supplier of X-ra...ll exhibit its full range of detectors at the RSNA...- December 3, 2009. Varian will also be exhibitin... well as specialized cancer treatment technologies...
Breaking Medicine Technology:Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7FDA Approves Agriflu Seasonal Influenza Vaccine 2Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Pre Diabetes Costs Nation 2425 Billion Annually in Extra Medical Care New Data Show 49982 1Pre Diabetes Costs Nation 2425 Billion Annually in Extra Medical Care New Data Show 49982 2Pre Diabetes Costs Nation 2425 Billion Annually in Extra Medical Care New Data Show 49982 3Pre Diabetes Costs Nation 2425 Billion Annually in Extra Medical Care New Data Show 49982 4Pre Diabetes Costs Nation 2425 Billion Annually in Extra Medical Care New Data Show 49982 5Pre Diabetes Costs Nation 2425 Billion Annually in Extra Medical Care New Data Show 49982 6A L L Promises Caritas Christi Investigation After July 1 49980 1A L L Promises Caritas Christi Investigation After July 1 49980 2A L L Promises Caritas Christi Investigation After July 1 49980 3Intercell Supports the Japanese Encephalitis Vaccination Recommendations of CDCs Advisory Committee on Immunization Practices 49978 1Intercell Supports the Japanese Encephalitis Vaccination Recommendations of CDCs Advisory Committee on Immunization Practices 49978 2Intercell Supports the Japanese Encephalitis Vaccination Recommendations of CDCs Advisory Committee on Immunization Practices 49978 3Intercell Supports the Japanese Encephalitis Vaccination Recommendations of CDCs Advisory Committee on Immunization Practices 49978 4
...ATTLE, July 23 Dendreon Corporation,(Nasdaq: DND...t Data,Monitoring Committee (IDMC) to review in Oc...l relating to the Company,s Phase 3 IMPACT (IMmuno...o known as D9902B) clinical trial,of PROVENGE(R) (...tional,active cellular immunotherapy for the treat...
...NNEAPOLIS, July 22 Nonin Medical, a leading innov...e than 20 years, has entered,the clinical testing ...regional oxygen saturation. Today,s most common ap...nitoring of the regional blood oxygenation,in the ...nd outcomes from an ongoing clinical study at the,...
Other Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2
(Date:11/26/2009)...rug tetrathiomolybdate (TM) has been shown in stud...ease, a disease caused by an overload of copper, a... Very little, however, is known about how the drug... by Northwestern University researchers now has pr...tructure of TM bound to copper-loaded metallochape...
(Date:11/26/2009)...en on an emotional rollercoaster, study finds , ...ll it the fear factor meets the jubilant sports fa...pecially those who root for the winning team -- en...ntested match and victory was in doubt, producing ...hat this Thanksgiving weekend as you,re glued to t...
(Date:11/26/2009)...r. David Kim of the Live Life Again Center, a prac...one of a growing number of physicians who are tak...o connect with individuals who are interested in s...ity. Dr. Kim is utilizing Facebook to share before...ce with the community. , ...
(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
(Date:11/25/2009)...ov. 25 When most people.... But a chiropractor can also give patients the h...lar Joint, which is where your jaw (mandible) cont..., The most common symptoms associated with TMJ d...ing of the jaw. But many other symptoms can be ca...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
...LLERTON, Calif., Dec. 4 Beckman Coulter,Inc. (NYS...marketer of,products that simplify, automate, and ...y that Scott Garrett, Beckman Coulter,s president ...(Logo: http://www.newscom.com/cgi-bin/prnh/200312...
...W YORK, Dec. 4 The holidays are all about bringin...er one roof, it also means,a lot more bacteria. Ho...e,and the potential for more bacteria in common ar...., , Listen to this report from Philips at:, http...
...nancing Provides Capital to Complete EVEREST Pivot...Commercialization Company Provides Updated..., Dec. 4 Evalve, Inc., the leader in,the developm...Fund LP led the round and was joined by investors ...
...ople in good shape tend to outlive folks who aren,...Day News) -- In the quest for a longer life, a new...u,re fat. , Overweight and obese seniors who were ...rong determinate of mortality in older men and wom...
... measures nervous system and heart,s electrical sy...-- A test of two heart functions accurately spotte...ath as they recovered from a heart attack, Canadia...uthor Dr. Derek V. Exner, associate professor of m...
...CKVILLE, Md., Dec. 4 Nabi,Biopharmaceuticals (Nas... the,sale of assets constituting its Biologics str...als Corporation, a wholly-owned subsidiary of Biot...ts,including Nabi- HB(R) and other plasma business...
Other Medicine News:Health News:UPDATED: Evalve(R) Completes $60 Million Series D Financing 2Health News:UPDATED: Evalve(R) Completes $60 Million Series D Financing 3Health News:Fitness, Not Fatness, Predicts a Longer Life 2Health News:2-in-1 Test Signals Risk After Heart Attack 2Health News:2-in-1 Test Signals Risk After Heart Attack 3Health News:Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG 2Health News:Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG 3
External Ventricular Drainage (EVD)
Bactiseal EVD Catheter
Monitorr ICP External CSF Drainage and Monitoring System
Sodem Skull Perforator Motor
Medicine Products: